Roche wins CE mark for first IVD ApoE4 blood test
The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4…
Roche’s Contivue Earns CE Mark for Continuous Eye Disease Treatment
Roche (OTCQX:RHHBY) has received CE mark approval for Contivue, its Port Delivery Platform…